Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 10:39AM ET
37.01
Dollar change
-0.86
Percentage change
-2.28
%
IndexRUT P/E- EPS (ttm)-4.64 Insider Own25.52% Shs Outstand34.21M Perf Week17.33%
Market Cap1.22B Forward P/E- EPS next Y-2.12 Insider Trans-1.07% Shs Float24.66M Perf Month34.61%
Income-135.89M PEG- EPS next Q-1.26 Inst Own85.07% Short Float22.96% Perf Quarter123.06%
Sales17.45M P/S70.19 EPS this Y6.35% Inst Trans2.06% Short Ratio7.24 Perf Half Y112.67%
Book/sh5.76 P/B6.43 EPS next Y51.06% ROA-55.01% Short Interest5.66M Perf Year138.90%
Cash/sh6.87 P/C5.39 EPS next 5Y- ROE-69.71% 52W Range11.33 - 40.40 Perf YTD82.74%
Dividend Est.- P/FCF- EPS past 5Y-132.82% ROI-59.52% 52W High-8.40% Beta1.05
Dividend TTM- Quick Ratio6.85 Sales past 5Y-17.43% Gross Margin85.48% 52W Low226.61% ATR (14)1.97
Dividend Ex-Date- Current Ratio6.93 EPS Y/Y TTM-80.72% Oper. Margin-820.53% RSI (14)72.54 Volatility9.32% 5.68%
Employees244 Debt/Eq0.16 Sales Y/Y TTM-32.42% Profit Margin-778.89% Recom1.33 Target Price45.33
Option/ShortYes / Yes LT Debt/Eq0.16 EPS Q/Q-157.80% Payout- Rel Volume0.28 Prev Close37.87
Sales Surprise138.99% EPS Surprise4.53% Sales Q/Q30.76% EarningsFeb 27 BMO Avg Volume782.45K Price37.01
SMA2018.91% SMA5044.13% SMA20092.51% Trades Volume48,149 Change-2.28%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Initiated Goldman Neutral $19
Jul-18-23Initiated William Blair Outperform $44
May-18-23Initiated Guggenheim Buy
Aug-01-22Initiated Barclays Overweight $40
Dec-21-21Initiated H.C. Wainwright Buy $40
Nov-23-21Initiated Oppenheimer Outperform $55
Nov-10-20Initiated Raymond James Strong Buy $39
Nov-10-20Initiated Ladenburg Thalmann Buy $42
Nov-10-20Initiated Jefferies Buy $35
Nov-10-20Initiated BofA Securities Buy $33
Feb-28-24 12:00PM
09:58AM
Feb-27-24 11:13PM
06:34AM
06:00AM
08:00AM Loading…
Feb-22-24 08:00AM
Feb-20-24 05:00PM
Jan-31-24 05:00PM
Jan-30-24 04:06AM
Jan-21-24 07:01AM
Dec-21-23 03:32PM
Dec-11-23 08:00AM
Dec-01-23 11:04PM
Nov-12-23 12:15PM
Nov-09-23 04:05PM
06:35PM Loading…
Nov-01-23 06:35PM
Sep-06-23 08:00AM
Aug-30-23 04:30PM
Aug-28-23 10:22AM
Aug-24-23 09:00AM
Aug-10-23 04:05PM
Aug-03-23 02:14PM
Aug-01-23 10:30PM
Jul-31-23 04:29PM
Jul-25-23 07:00AM
Jul-20-23 02:04PM
Jul-19-23 08:34PM
10:13AM
Jun-12-23 08:30AM
Jun-05-23 08:30AM
04:05PM Loading…
May-09-23 04:05PM
May-08-23 08:30AM
May-05-23 08:22AM
May-03-23 04:30PM
Apr-24-23 08:30AM
Apr-18-23 06:04AM
Apr-06-23 03:52PM
Mar-17-23 06:28AM
Mar-13-23 04:05PM
Mar-09-23 10:00AM
Mar-02-23 04:30PM
Feb-24-23 11:44AM
Jan-24-23 04:33AM
Dec-16-22 07:00AM
Dec-15-22 12:45PM
08:30AM
Dec-08-22 06:55AM
Nov-11-22 06:03AM
Nov-09-22 08:45AM
07:00AM
Oct-25-22 08:30AM
Oct-17-22 09:26AM
Oct-11-22 08:30AM
Oct-06-22 08:30AM
Sep-29-22 08:30AM
Sep-27-22 12:00PM
Sep-17-22 10:23AM
Sep-07-22 07:00AM
Aug-11-22 05:25PM
04:05PM
Aug-05-22 08:30AM
Jul-25-22 08:00AM
Jun-29-22 06:51AM
May-27-22 09:00AM
May-14-22 08:19AM
May-11-22 06:30AM
May-10-22 06:55PM
04:05PM
May-09-22 01:49PM
May-06-22 09:00AM
May-05-22 08:30AM
May-03-22 03:00PM
06:58AM
May-02-22 07:01AM
07:00AM
Apr-29-22 09:23PM
Apr-26-22 08:30AM
Apr-21-22 03:05AM
Mar-14-22 04:05PM
Mar-09-22 05:00PM
Feb-03-22 09:00AM
Feb-02-22 04:30PM
07:00AM
Jan-04-22 09:00AM
Nov-23-21 04:30PM
Nov-10-21 04:30PM
Nov-09-21 04:05PM
Nov-05-21 12:04PM
Nov-04-21 11:28AM
09:45AM
Nov-02-21 05:00PM
Oct-19-21 02:38PM
Oct-11-21 07:43PM
Aug-13-21 07:07AM
Aug-12-21 09:00AM
Aug-07-21 04:20AM
Aug-04-21 05:30PM
Jul-24-21 06:00PM
Jul-20-21 08:37AM
Jul-07-21 04:05PM
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Azamian Bobak R.President/CEO and Board ChairDec 27Sale20.228,000161,760830,106Dec 29 05:08 PM
Azamian Bobak R.President/CEO and Board ChairDec 20Sale20.2740,000810,623838,106Dec 22 05:30 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERDec 20Sale20.002,25245,0402,251Dec 22 05:32 PM
Goldberg Andrew D.DirectorDec 15Buy18.961,00018,9603,000Dec 19 06:30 PM
Wahl BryanGeneral CounselNov 30Sale16.318,356136,28631,966Dec 01 04:55 PM
Whitfield Dianne C.Chief Human Resources OfficerNov 30Sale16.318,355136,27026,784Dec 01 04:58 PM
Whitfield Dianne C.Chief Human Resources OfficerNov 29Option Exercise0.0023,920035,139Dec 01 04:58 PM
Wahl BryanGeneral CounselNov 29Option Exercise0.0023,920040,322Dec 01 04:55 PM
Azamian Bobak R.President/CEO and Board ChairNov 15Sale18.378,000146,933878,106Nov 17 04:50 PM
Azamian Bobak R.President/CEO and Board ChairOct 18Sale13.248,000105,920886,106Oct 20 04:41 PM
Trevejo Jose M.CHIEF MEDICAL OFFICEROct 05Sale18.001,60428,8724,503Oct 06 05:21 PM
Azamian Bobak R.President/CEO and Board ChairSep 20Sale17.218,000137,680894,106Sep 22 05:30 PM
Azamian Bobak R.President/CEO and Board ChairAug 23Sale17.238,000137,840902,106Aug 25 05:12 PM
Lin Elizabeth YeuDirectorAug 15Buy16.809,506159,70115,866Aug 17 06:02 PM
Azamian Bobak R.President/CEO and Board ChairJul 19Sale20.01103,9002,078,984910,106Jul 21 05:42 PM
Mottiwala AzizChief Commercial OfficerJul 19Sale20.052,40048,12045,806Jul 21 05:46 PM
Azamian Bobak R.President/CEO and Board ChairJul 12Sale17.359,000156,1501,014,006Jul 14 04:40 PM
Azamian Bobak R.President/CEO and Board ChairJun 21Sale18.638,000149,0401,023,006Jun 23 04:29 PM
Azamian Bobak R.President/CEO and Board ChairJun 14Sale18.589,000167,2201,031,006Jun 16 04:48 PM
Azamian Bobak R.President/CEO and Board ChairJun 08Sale20.013,10062,0311,040,006Jun 12 05:40 PM
Mottiwala AzizChief Commercial OfficerJun 08Sale20.001002,00048,086Jun 12 05:25 PM
Mottiwala AzizChief Commercial OfficerJun 07Sale19.342,50048,35048,186Jun 08 07:16 PM
Mottiwala AzizChief Commercial OfficerJun 06Sale18.612,14339,88150,686Jun 08 07:16 PM
Azamian Bobak R.President/CEO and Board ChairMay 17Sale15.908,000127,2001,043,106May 19 07:08 PM
Azamian Bobak R.President/CEO and Board ChairMay 10Sale16.809,000151,2001,051,106May 12 05:08 PM
Azamian Bobak R.President/CEO and Board ChairMay 01Sale15.105,84188,1991,060,106May 02 07:06 PM
Azamian Bobak R.President/CEO and Board ChairApr 28Sale15.134,27864,7261,065,947May 02 07:06 PM
Azamian Bobak R.President/CEO and Board ChairApr 21Sale15.032,31134,7341,070,225Apr 25 05:22 PM
Greenstein Leonard M.Chief Financial OfficerApr 20Sale14.025,00070,10026,785Apr 21 05:53 PM
Azamian Bobak R.President/CEO and Board ChairApr 19Sale13.608,000108,8001,072,536Apr 21 05:49 PM
Azamian Bobak R.President/CEO and Board ChairMar 23Sale12.157378,9558,597Mar 23 07:50 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 23Sale12.154655,6506,107Mar 23 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 23Sale12.153904,73854,696Mar 23 07:56 PM
Mottiwala AzizChief Commercial OfficerMar 23Sale12.153724,52052,829Mar 23 07:46 PM
Wahl BryanGeneral CounselMar 23Sale12.153714,50816,402Mar 23 07:52 PM
Greenstein Leonard M.Chief Financial OfficerMar 23Sale12.153464,20431,785Mar 23 08:04 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 23Sale12.153454,19211,219Mar 23 07:48 PM
Azamian Bobak R.President/CEO and Board ChairMar 22Sale12.647098,9629,334Mar 23 07:50 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 22Sale12.645296,6876,572Mar 23 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 22Sale12.643794,79155,086Mar 23 07:56 PM
Mottiwala AzizChief Commercial OfficerMar 22Sale12.643574,51253,201Mar 23 07:46 PM
Wahl BryanGeneral CounselMar 22Sale12.643574,51216,773Mar 23 07:52 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 22Sale12.643334,20911,564Mar 23 07:48 PM
Greenstein Leonard M.Chief Financial OfficerMar 22Sale12.643324,19632,131Mar 23 08:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 21Sale12.896798,75210,043Mar 23 07:50 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 21Sale12.895196,6907,101Mar 23 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 21Sale12.893724,79555,465Mar 23 07:56 PM
Wahl BryanGeneral CounselMar 21Sale12.893504,51217,130Mar 23 07:52 PM
Mottiwala AzizChief Commercial OfficerMar 21Sale12.893494,49953,558Mar 23 07:46 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 21Sale12.893264,20211,897Mar 23 07:48 PM
Greenstein Leonard M.Chief Financial OfficerMar 21Sale12.893264,20232,463Mar 23 08:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 20Sale12.617419,34410,722Mar 21 07:01 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 20Sale12.615306,6837,620Mar 21 07:10 PM
Neervannan SeshadriChief Operating OfficerMar 20Sale12.613804,79255,837Mar 21 07:12 PM
Mottiwala AzizChief Commercial OfficerMar 20Sale12.613584,51453,907Mar 21 07:08 PM
Wahl BryanGeneral CounselMar 20Sale12.613574,50217,480Mar 21 07:14 PM
Greenstein Leonard M.Chief Financial OfficerMar 20Sale12.613334,19932,789Mar 21 07:03 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 20Sale12.613334,19912,223Mar 21 07:17 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 20Sale12.611982,4973,191Mar 21 07:06 PM
Azamian Bobak R.President/CEO and Board ChairMar 17Sale13.2879510,55811,463Mar 21 07:01 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 17Sale13.285046,6938,150Mar 21 07:10 PM
Neervannan SeshadriChief Operating OfficerMar 17Sale13.283604,78156,217Mar 21 07:12 PM
Mottiwala AzizChief Commercial OfficerMar 17Sale13.283394,50254,265Mar 21 07:08 PM
Wahl BryanGeneral CounselMar 17Sale13.283394,50217,837Mar 21 07:14 PM
Greenstein Leonard M.Chief Financial OfficerMar 17Sale13.283164,19633,122Mar 21 07:03 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 17Sale13.283164,19612,556Mar 21 07:17 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 17Sale13.281882,4973,389Mar 21 07:06 PM
Greenstein Leonard M.Chief Financial OfficerMar 16Sale13.445,31371,40433,438Mar 17 06:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 16Sale13.4379110,62312,258Mar 17 06:02 PM
Trevejo Jose M.Chief Medical OfficerMar 16Sale13.434996,7028,654Mar 17 06:18 PM
Neervannan SeshadriChief Operating OfficerMar 16Sale13.433574,79556,577Mar 17 06:15 PM
Wahl BryanGeneral CounselMar 16Sale13.433374,52618,176Mar 17 06:21 PM
Mottiwala AzizChief Commercial OfficerMar 16Sale13.433364,51254,604Mar 17 06:17 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 16Sale13.433134,20412,872Mar 17 06:20 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 16Sale13.431872,5113,577Mar 17 06:22 PM
Azamian Bobak R.President/CEO and Board ChairMar 15Sale13.798,000110,3201,080,536Mar 17 06:02 PM
Azamian Bobak R.President/CEO and Board ChairMar 09Sale15.0171710,7621,088,536Mar 10 05:13 PM
Azamian Bobak R.President/CEO and Board ChairMar 08Sale15.024,85372,8921,089,253Mar 10 05:13 PM